ResMed (NYSE:RMD) Q2 2026 Earnings call January 29, 2026 04:30 PM ET Company ParticipantsBrett Sandercock - CFOJon Block - Managing Director for Medical Technology and SuppliesMick Farrell - CEO and ChairmanNathan Treybeck - VP of Equity Research for Medical DevicesSalli Schwartz - Chief Investor Relations OfficerConference Call ParticipantsAnthony Petrone - Managing Director and Senior Medical Devices, Diagnostics and Therapeutics Equity Research AnalystBrandon Vazquez - Equity Research Analyst for Healthc ...